Betamethasone
Betamethasone is a topical corticosteroid used to relieve inflammation and itching caused by skin conditions, including corticosteroid-responsive dermatoses and plaque psoriasis.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 83 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Betamethasone: Patient Information Guide
A plain-language walkthrough of Betamethasone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Betamethasone is a topical corticosteroid available in several formulations and brands, each with specific approved uses.
- Betamethasone Dipropionate creams, ointments, and gels (including Diprolene Ointment) treat itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
- Betamethasone Valerate cream and ointment treat itching and inflammation from corticosteroid-responsive dermatoses
- Betamethasone valerate foam is specifically approved for corticosteroid-responsive dermatoses of the scalp
- Betamethasone dipropionate spray and Sernivo Spray are specifically approved for mild to moderate plaque psoriasis in adults 18 years and older
⚙️How it works▾
Betamethasone is a corticosteroid — a type of steroid that works within skin cells to dial down inflammation. It influences immune signaling, reduces inflammatory chemicals, and calms the overactive immune response that causes the redness, swelling, and itching seen in skin conditions. The exact way it helps plaque psoriasis specifically is not fully known, but its anti-inflammatory action is central to its effect.
💊How it's taken▾
The right way to use betamethasone depends on which product you have. Creams and ointments are generally applied as a thin film once or twice a day. Betamethasone Valerate lotion is applied as a few drops massaged in lightly, typically twice a day. The foam for scalp conditions is dispensed onto a cool surface and massaged in twice daily. Sprays (betamethasone dipropionate spray and Sernivo) are shaken before use and applied twice daily for up to 4 weeks.
- Discontinue use when the skin condition is controlled — don't use longer than needed
- If there's no improvement after 2 weeks (or 4 weeks for sprays), contact your prescriber
- Do not use with tight bandages or wraps (occlusive dressings) unless your doctor says so
- For all forms: avoid the face, groin, and underarms unless directed by your doctor
🤒Side effects — in detail▾
The most common side effects are at the spot where you apply the medication. These include:
- Itching, burning, or stinging at the application site
- Pain at the application site
- Skin thinning (atrophy)
- Stretch marks (striae)
- Folliculitis (inflamed hair follicles)
- Skin irritation, dryness, or discoloration
- Acne-like breakouts
- Hypopigmentation (lightening of the skin)
More serious reactions — including signs of hormone suppression (unusual fatigue or weakness), eye problems like cataracts or glaucoma, or signs of allergic contact dermatitis — require prompt medical attention.
⚠️Warnings & precautions▾
- HPA axis suppression (adrenal suppression): Using too much betamethasone or applying it over large areas of skin for too long can interfere with your body's ability to produce cortisol — a hormone you need for stress response. High-potency formulations, broken skin, liver problems, and use under dressings increase this risk. Children are especially vulnerable.
- Eye risks: Getting this medication near your eyes — or using it around the eye area — can raise the risk of cataracts and glaucoma over time. Always avoid eye contact and report any new vision changes.
- Skin thinning and other skin changes: Long-term use can cause the skin to become thin, develop stretch marks, or show changes in color. Do not use on areas that already have skin thinning.
- Allergic contact dermatitis: If your skin condition stops improving or gets worse, it could be an allergic reaction to the product itself. Talk to your doctor if this happens.
- Pregnancy: Using large amounts of potent topical corticosteroids during pregnancy has been linked to a risk of low birth weight. Use the smallest effective amount for the shortest time.
🔀What it interacts with▾
The FDA labels for betamethasone topical products do not describe specific drug-drug or drug-food interactions. Always tell your prescriber and pharmacist about all medications and supplements you take.
- Using betamethasone under tight bandages or occlusive dressings increases how much is absorbed through the skin — this is not a drug interaction but raises the risk of systemic side effects
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are allergic to betamethasone, other corticosteroids, or any ingredient in the specific product
- Tell your doctor if you are pregnant — heavy or prolonged use of potent topical corticosteroids may increase the risk of low birth weight in the baby
- If you are breastfeeding, avoid applying to the nipple or areola; discuss benefits and risks with your doctor
- Most betamethasone topical products are not recommended for children under 13 years of age (some under 12) due to a higher risk of adrenal suppression
- Patients with liver failure may absorb more through the skin and should use these products with extra care
- Do not apply to areas where the skin is already thin (atrophy is present)
- Avoid the face, groin, underarms, and skin folds unless your prescriber specifically instructs you to use it there
📡Pharmacodynamics — effects in the body▾
When applied to the skin, betamethasone works as a vasoconstrictor — meaning it narrows blood vessels — which is one marker of its anti-inflammatory potency. Betamethasone dipropionate spray, for example, is considered mid-range in potency compared to other topical corticosteroids based on these vasoconstriction studies. Used over large areas of skin, it can measurably affect the body's cortisol levels, reflecting absorption beyond just the skin surface.
🔬Pharmacokinetics — how your body processes it▾
How much betamethasone gets absorbed through the skin depends on several factors: the specific vehicle (cream, ointment, spray, etc.), whether the skin barrier is intact, and whether occlusive dressings are used. Inflamed or damaged skin absorbs more of the medication than healthy, intact skin. In studies of betamethasone dipropionate spray, most subjects had no measurable drug levels in the bloodstream, suggesting minimal systemic absorption under typical conditions.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F) .
📄 Written from Betamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Betamethasone — the kind of thing our pharmacy team would talk through with you at the counter.
What skin conditions does betamethasone treat? ▾
How do I apply it correctly? ▾
How long can I use betamethasone? ▾
What side effects should I watch out for? ▾
Is it safe to use if I'm pregnant or breastfeeding? ▾
Can I cover the skin with a bandage after applying betamethasone? ▾
Is Betamethasone available over the counter? ▾
When was Betamethasone first available? ▾
Who makes Betamethasone? ▾
💬 Answers drafted from Betamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Betamethasone comes
Betamethasone is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Betamethasone Dipropionate cream and ointment are used to relieve itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
- Betamethasone Valerate cream and ointment are used to relieve itching and inflammation from corticosteroid-responsive dermatoses
- Diprolene Ointment is used to relieve itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
- Betamethasone Dipropionate and Diprolene Ointment: apply a thin film to the affected area once or twice daily; do not exceed 50 g per week
- Betamethasone Valerate cream or ointment: apply a thin film one to three times a day; once or twice daily is often effective
- Diprolene Ointment: avoid use on the face, groin, or underarms, and avoid contact with eyes; wash hands after each application
- All creams and ointments: do not use with occlusive dressings unless directed by a physician, and discontinue when the condition is controlled
Inhaler
How this form is used
- Betamethasone valerate foam is used to relieve itching and inflammation from corticosteroid-responsive dermatoses of the scalp
- Betamethasone valerate foam: invert the can to dispense a small amount onto a cool surface — do not dispense directly onto hands
- Betamethasone valerate foam: pick up small amounts with fingers and gently massage into the affected scalp area until it disappears
- Betamethasone valerate foam: apply twice daily, once in the morning and once at night
- Betamethasone valerate foam: do not use with occlusive dressings unless directed by a physician
Topical spray
How this form is used
- Betamethasone dipropionate spray is indicated for mild to moderate plaque psoriasis in adults 18 years and older
- Sernivo Spray is indicated for mild to moderate plaque psoriasis in adults 18 years and older
- Betamethasone dipropionate spray and Sernivo Spray: shake well before use, apply to affected areas twice daily, and rub in gently
- Betamethasone dipropionate spray and Sernivo Spray: use for up to 4 weeks only — treatment beyond 4 weeks is not recommended
- Betamethasone dipropionate spray and Sernivo Spray: avoid use on the face, scalp, underarms, groin, or other skin folds
- Betamethasone dipropionate spray and Sernivo Spray: do not bandage, cover, or wrap the treated area unless directed by a physician
📊 Betamethasone across the U.S. market
How Betamethasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (44) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Betamethasone is used
A general measure of how commonly Betamethasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Betamethasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Betamethasone prescribed? Of the 1,596 medications we measure, Betamethasone ranks #288 by Medicaid prescriptions — more than 82% of them.
Utilization by Betamethasone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
betamethasone 0.5 MG/ML Topical Cream Most dispensed
Summed across the 12 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 238920
betamethasone 1 MG/ML Topical Cream
Summed across the 6 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197407
betamethasone 0.0005 MG/MG Topical Ointment
Summed across the 10 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197405
betamethasone 0.001 MG/MG Topical Ointment
Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197409
Augmented betamethasone 0.5 MG/ML Topical Cream
Summed across the 4 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848176
betamethasone 0.5 MG/ML Topical Lotion
Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 240209
Augmented betamethasone 0.0005 MG/MG Topical Ointment
Summed across the 10 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848180
betamethasone 1 MG/ML Topical Lotion
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197408
Augmented betamethasone 0.5 MG/ML Topical Lotion
Summed across the 4 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848178
betamethasone valerate 1.2 MG/ML Topical Foam
Summed across the 6 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1244634
Augmented betamethasone 0.0005 MG/MG Topical Gel
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848208
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Betamethasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 62 of 171 listed Betamethasone NDCs with Medicaid activity.
🔍 Compare Betamethasone products
A representative set of FDA-listed product records for Betamethasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 1.2 mg/g | Topical | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 1.2 mg/g | Topical | Ingenus Pharmaceuticals LLC | ANDA | View NDC → |
| 1.2 mg/g | Topical | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1.2 mg/g | Topical | Mylan Pharmaceuticals Inc. | NDA | View NDC → |
| 1.2 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 3 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | Xiromed, LLC. | ANDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.5 mg/g | Topical | A-S Medication Solutions × 19 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | A-S Medication Solutions × 5 listings | NDA | View NDC → |
| 1 mg/g | Topical | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | A-S Medication Solutions × 4 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Actavis Pharma, Inc. × 7 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Asclemed USA, Inc | ANDA | View NDC → |
| 0.5 mg/g | Topical | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Bryant Ranch Prepack × 12 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Burel Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Cosette Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | Cosette Pharmaceuticals, Inc. | NDA | View NDC → |
| 1.2 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 4 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 3 listings | ANDA | View NDC → |
| 1 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| 1 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 1 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | NDA | View NDC → |
| 0.5 mg/mL | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | McKesson Corporation | ANDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Northstar Rx LLC. × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 6 listings | ANDA | View NDC → |
| 1 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | NuCare Pharmaceuticals,Inc. | NDA | View NDC → |
| 1.2 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 4 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Organon LLC × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 7 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Prasco Laboratories × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/g | Topical | Preferred Pharmaceuticals, Inc. × 8 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Preferred Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 1.2 mg/g | Topical | Preferred Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Preferred Pharmaceuticals Inc. × 4 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Preferred Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Proficient Rx LP | NDA | View NDC → |
| 1.2 mg/g | Topical | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Redpharm Drug | ANDA | View NDC → |
| 0.5 mg/g | Topical | Remedyrepack Inc. × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Remedyrepack Inc. × 3 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Remedyrepack Inc. | NDA | View NDC → |
| 1.2 mg/g | Topical | Remedyrepack Inc. × 2 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | RPK Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg/g | Topical | RPK Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 1 mg/g | Topical | RPK Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1.2 mg/g | Topical | RPK Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg/mL | Cutaneous | STI Pharma LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. × 4 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Teligent Pharma, Inc. | ANDA | Find on DailyMed ↗ |
| 0.5 mg/mL | Topical | Teligent Pharma, Inc. | ANDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Viona Pharmaceuticals Inc × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Zydus Lifesciences Limited × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Apicore Pharmaceuticals Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Curia Spain S.A.U. × 3 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Curia Spain SAU | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Farmabios S.p.A. × 2 listings | BULK INGREDIENT | View NDC → |
Showing 200 of 244 products — FDA National Drug Code Directory. See every product, package size and price: browse all 244 Betamethasone NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Betamethasone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Betamethasone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Betamethasone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 1514 13 dose forms · 22 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 379265No current FDA listingClinical drug / strength (SCD) 0.5 MGRxCUI 105389 -
Dose form (SCDF) Injectable Solution RxCUI 371049No current FDA listingClinical drug / strength (SCD) 4 MG/MLRxCUI 308718 -
Dose form (SCDF) Injectable Suspension RxCUI 378340No current FDA listingClinical drug / strength (SCD) 6 MG/MLRxCUI 1660745 -
Dose form (SCDF) Ophthalmic Ointment RxCUI 376457No current FDA listingClinical drug / strength (SCD) 0.001 MG/MGRxCUI 249596 -
Dose form (SCDF) Oral Solution RxCUI 371053No current FDA listingClinical drug / strength (SCD) 0.12 MG/MLRxCUI 670084 -
Dose form (SCDF) Oral Tablet RxCUI 371056No current FDA listingClinical drug / strength (SCD) 0.5 MGRxCUI 2452580.6 MGRxCUI 308709 -
Dose form (SCDF) Topical Cream RxCUI 377613In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.5 MG/MLRxCUI 8481760.5 MG/MLRxCUI 2389201 MG/MLRxCUI 197407 -
Dose form (SCDF) Topical Foam RxCUI 384499In current FDA listingsClinical drug / strength (SCD) valerate 1.2 MG/MLRxCUI 1244634 -
Dose form (SCDF) Topical Gel RxCUI 377967In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.0005 MG/MGRxCUI 8482080.0005 MG/MGRxCUI 240571 -
Dose form (SCDF) Topical Lotion RxCUI 377614In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.5 MG/MLRxCUI 8481780.5 MG/MLRxCUI 2402091 MG/MLRxCUI 197408 -
Dose form (SCDF) Topical Ointment RxCUI 374614In current FDA listingsClinical drug / strength (SCD) Augmented betamethasone 0.0005 MG/MGRxCUI 8481800.0005 MG/MGRxCUI 1974050.001 MG/MGRxCUI 1974090.005 MG/MGRxCUI 895257 -
Dose form (SCDF) Topical Solution RxCUI 371057No current FDA listingClinical drug / strength (SCD) 1 MG/MLRxCUI 250861 -
Dose form (SCDF) Topical Spray RxCUI 377311In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 1738536
Look up RxCUI 1514 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Betamethasone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Betamethasone belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 83 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Primus Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.